Setiptiline
Antidepressant drug
From Wikipedia, the free encyclopedia
Setiptiline (brand name Tecipul), also known as teciptiline, is a tetracyclic antidepressant (TeCA) that acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). It was launched in 1989 for the treatment of depression in Japan by Mochida.[1][2]
| Clinical data | |
|---|---|
| Trade names | Tecipul |
| Other names | Teciptiline; delta(13b,4a),4a-Carba-mianserin; MO-8282; ORG-8282 |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.055.123 |
| Chemical and physical data | |
| Formula | C19H19N |
| Molar mass | 261.368 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Pharmacology
Pharmacodynamics
| Site | Ki (nM) | Species | Ref |
|---|---|---|---|
| SERT | >10,000 (IC50) | Rat | [4] |
| NET | 220 (IC50) | Rat | [4] |
| DAT | >10,000 (IC50) | Rat | [4] |
| 5-HT1A | ND | ND | ND |
| 5-HT2A | ND | ND | ND |
| 5-HT2C | ND | ND | ND |
| α1 | ND | ND | ND |
| α2 | 24.3 (IC50) | Rat | [5] |
| H1 | ND | ND | ND |
| mACh | ND | ND | ND |
| Values are Ki (nM), unless otherwise noted. The smaller the value, the more strongly the drug binds to the site. | |||
Setiptiline acts as a norepinephrine reuptake inhibitor,[4] α2-adrenergic receptor antagonist,[5] and serotonin receptor antagonist,[6] likely at the 5-HT2 subtypes,[citation needed] as well as an H1 receptor inverse agonist/antihistamine.[4][additional citation(s) needed]
Chemistry
Setiptiline has a tetracyclic structure and is a close analogue of mianserin and mirtazapine, with setiptiline being delta(13b,4a),4a-carba-mianserin, and mirtazapine being 6-azamianserin.